OPKO Health, Inc. Capital Leases, Balance Sheet, Assets by Major Class, Net
OPKO Health, Inc. (OPK) had Capital Leases, Balance Sheet, Assets by Major Class, Net of $5.08 million as of 2018-12-31, per its 10-K filed 2019-03-01.
Discontinued › Notes › Leases
us-gaap:CapitalLeasesBalanceSheetAssetsByMajorClassNet · last filed 2019-03-01
- 2018-12-31: Capital Leases, Balance Sheet, Assets by Major Class, Net $5.08M.
- 2017-12-31: Capital Leases, Balance Sheet, Assets by Major Class, Net $6.77M.
- 2016-12-31: Capital Leases, Balance Sheet, Assets by Major Class, Net $7.05M.
- 2015-12-31: Capital Leases, Balance Sheet, Assets by Major Class, Net $50.09M.
| Period end | Capital Leases, Balance Sheet, Assets by Major Class, Net |
|---|---|
| 2018-12-31 | $5.08M 10-K · filed 2019-03-01 |
| 2017-12-31 | $6.77M 8-K · filed 2019-01-29 |
| 2016-12-31 | $7.05M 10-K · filed 2017-03-01 |
| 2015-12-31 | $50.09M 10-K · filed 2016-02-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |
| HARROW, INC. (HROW) | United States | $1.240B | -42.77 |
| Damora Therapeutics, Inc. (DMRA) | $1.250B | -6.10 | |
| Jaguar Health, Inc. (JAGX) | United States | $1.184B | |
| Latigo Biotherapeutics, Inc. (LTGO) | United States | $1.176B | |
| Avalyn Pharma Inc. (AVLN) | United States | $1.267B | |
| First Tracks Biotherapeutics, Inc. (TRAX) | United States | $1.280B | |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B | |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |